(Q27692669)

English

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

1 reference

6 November 2020

systematic review

1 reference

PubMed publication ID

1 reference

PubMed publication ID

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis (English)

1 reference

non-small-cell lung carcinoma

1 reference

6 November 2020

1 reference

6 November 2020

1 reference

31 July 2019

1 reference

6 November 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Zhang Z

1

1 reference

Wang T

2

1 reference

Zhang J

3

1 reference

Cai X

4

1 reference

Pan C

5

1 reference

Long Y

6

1 reference

Chen J

7

1 reference

Zhou C

8

1 reference

Yin X

9

1 reference

language of work or name

0 references

publication date

27 August 2014

9 references

3 April 2019

20 June 2019

30 June 2019

31 July 2019

14 September 2019

28 September 2019

15 December 2019

6 November 2020

9 references

3 April 2019

20 June 2019

30 June 2019

31 July 2019

14 September 2019

28 September 2019

15 December 2019

6 November 2020

9

1 reference

8

1 reference

e106053

1 reference

copyright license

Creative Commons Attribution 4.0 International

8 references

Europe PubMed Central

3 April 2019

Europe PubMed Central

20 June 2019

Europe PubMed Central

30 June 2019

Europe PubMed Central

31 July 2019

Europe PubMed Central

14 September 2019

Europe PubMed Central

28 September 2019

Europe PubMed Central

15 December 2019

Europe PubMed Central

6 November 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

20 March 2017

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

20 March 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

20 March 2017

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

20 March 2017

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

20 March 2017

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

20 March 2017

The use of bevacizumab in non-small cell lung cancer: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

29 September 2017

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

2 June 2018

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Epidermal growth factor receptor mutation status and adjuvant chemotherapy in resected advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Time trend and geographic patterns of lung adenocarcinoma in the United States, 1973-2002

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106053

21 January 2018

[Predictive role of EGFR mutation status on postoperative prognosis in patients with resected lung adenocarcinomas].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

27 November 2018

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

27 November 2018

Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146589

27 November 2018

Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25162713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25162713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25162713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0106053

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2014PLoSO...9j6053Z

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

PubMed publication ID

1 reference

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27692669&oldid=1732500202"